ENTtoday
  • Home
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Multimedia
    • Video
    • Audio
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

FDA Guidance on Sinusitis and Its Potential Impact on Treatment

by Bradley F. Marple, MD • April 1, 2008

  • Tweet
  • Email
Print-Friendly Version

Fortunately, some efficacy and safety data are available for medical treatment of CRS. The solitary Cochrane systematic review related to medical management of CRS supports the role of nasal saline for symptom relief. In a similar fashion, data exist that support the role of several intranasal corticosteroids in the treatment of nasal polyposis.7 At present, these intranasal corticosteroid trials are the only studies that have been subjected to the regulatory oversight of the FDA, thus raising the validity of the resultant data and its interpretation to that of the standard for medical treatment of other disease processes.

You Might Also Like

  • Are Antibiotics Indicated for Acute Sinusitis?
  • Sublingual Immunotherapy a Potential Treatment for Allergic Rhinitis
  • For Chronic Sinusitis, Give Antibiotics a Longer Chance to Work Before Surgery
  • Targeted Therapy a Potential Treatment for Head and Neck Cancer
Explore This Issue
April 2008

So, why do no FDA-approved medications indicated for the treatment of CRS exist? The answer is simple. Until recently, the FDA did not endorse a definition for CRS. Given the extensive costs related to drug development, this absence of a simple working definition for chronic rhinosinusitis essentially removed all incentive to the pharmaceutical industry for investment in a drug that could never receive an indication for its targeted disease process. In fact, the current indications for intranasal corticosteroid sprays exist for nasal polyposis and not for chronic rhinosinusitis, representing a fortunate loophole of sorts. So, what appears to be crucial to the development of improved treatment modalities for CRS is the collaborative cooperation of physician groups, industry, and regulatory agencies.

Collaborations among academic researchers, regulatory agencies, and pharmaceutical manufacturers have long existed, and have served an important role in the process of preclinical and clinical drug development programs. The relationships and motivations of each of the bodies are, by their very nature, adversarial at times. Nevertheless, it is this very collaboration that appears to be necessary to move forward. During product development, conflicts of interest arise, which are impossible to avoid and instead must be acknowledged and managed. The innate conflicts that present within these collaborations must be balanced with the potential to develop new products for patient care.8

Steps in the Right Direction

Reflecting on the course of events that have lead to recent regulatory changes, it is clear that efforts by members of the medical community set the stage to move forward. In 2002, Michael Benninger, MD, under the direction of the Sinus and Allergy Health Partnership, convened a task force to define chronic rhinosinusitis. The results of that meeting resulted in the first published definition for chronic rhinosinusitis. In its most simplified form, chronic rhinosinusitis was defined as an inflammatory process involving the mucosa of the nose and paranasal sinuses lasting for more than 12 weeks.2 This definition served as a catalyst for further discussion and codification of a definition for the disease. Opposition to certain nuances of the definition was voiced. Two areas of continued difference relate to the use of the term rhinosinusitis as opposed to sinusitis, and to temporal aspects of the disease, but the fundamentals of the definition arguably remained largely intact.

Pages: 1 2 3 4 5 | Single Page

Filed Under: Departments, Health Policy, Medical Education, Practice Focus, Rhinology Tagged With: guidelines, healthcare reform, medication, outcomes, patient safety, policy, research, rhinosinusitis, Sinusitis, steroids, treatmentIssue: April 2008

You Might Also Like:

  • Are Antibiotics Indicated for Acute Sinusitis?
  • Sublingual Immunotherapy a Potential Treatment for Allergic Rhinitis
  • For Chronic Sinusitis, Give Antibiotics a Longer Chance to Work Before Surgery
  • Targeted Therapy a Potential Treatment for Head and Neck Cancer

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Is There a Crisis in the Otolaryngology Match?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Vertigo in the Elderly: What Does It Mean?
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Post-Tonsillectomy Taste Disorders Rare but Present
    • 10 Novel Ways to Disseminate Scientific Information
    • How to Work with Sales and Marketing Representatives in Your Medical Practice
    • How Medicine Helped Surgeon Prepare for Career as Writer
    • Best Practices for Emergency Surgical Airway
    • Spare Roof Technique Can Improve Patient Quality of Life after Rhinoplasty

Polls

Will registry information and data science improve patient care?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2019 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.